# EDGAR Filing Document

**Accession Number:** 0001802768
**File Stem:** 0001140361-26-014241
**Filing Date:** 2026-4
**Character Count:** 2469
**Document Hash:** b5324b0e3858dcb5df24f7fb46a05646
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-26-014241.hdr.sgml**: 20260410

**ACCESSION NUMBER**: 0001140361-26-014241

**CONFORMED SUBMISSION TYPE**: DEFA14A

**PUBLIC DOCUMENT COUNT**: 4

**FILED AS OF DATE**: 20260410

**DATE AS OF CHANGE**: 20260410

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Royalty Pharma plc
- **CENTRAL INDEX KEY:** 0001802768
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** DEFA14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39329
- **FILM NUMBER:** 26854983

**BUSINESS ADDRESS:**
- **STREET 1:** 110 EAST 59TH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** (212) 883-0200

**MAIL ADDRESS:**
- **STREET 1:** 110 EAST 59TH STREET
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

### UNITED STATES<br>

### SECURITIES AND EXCHANGE COMMISSION<br>

#### Washington, D.C. 20549

### SCHEDULE 14A

#### Proxy Statement Pursuant to Section 14(a)<br>

#### of the Securities Exchange Act of 1934<br>

#### (Amendment No.)
<br> ☒ Filed by the Registrant ☐ Filed by a Party other than the Registrant <br>

---

| | |
|:---|:---|
| **Check the appropriate box:**  | **Check the appropriate box:**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ | Preliminary Proxy Statement  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ | **CONFIDENTIAL, FOR USE OF THE COMMISSION ONLY (AS PERMITTED BY RULE 14a-6(e)(2))**  |
| ☐ | Definitive Proxy Statement  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☒ | Definitive Additional Materials  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ | Soliciting Material Under Rule §240.14a-12 |

---

#### <br>

---

| |
|:---|
| **ROYALTY PHARMA PLC**  |
| **(Name of Registrant as Specified In Its Charter)** |
| **(Name of Person(s) Filing Proxy Statement, if other than the Registrant)** |

---

---

| | |
|:---|:---|
| Payment of Filing Fee (Check the appropriate box):  | Payment of Filing Fee (Check the appropriate box):  |
| ☒ | No fee required.  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ | Fee paid previously with preliminary materials.  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |

---

------

![](ny20066979x2_na01.jpg)

------

![](ny20066979x2_na02.jpg)

------